Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as
selective dopamine D3 receptor agonists
Yongkai Cao,‡abc Ningning Sun,‡b Jiumei Zhang,‡c Zhiguo Liu,d Yi-zhe Tang,c Zhengzhi Wu,*c Kyeong-Man Kim*b and Seung Hoon Cheon*b
a Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, Guangzhou 510632, China
b College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 500-757, Republic of Korea
c The Fist Affiliated Hospital of Shenzhen University, Shenzhen 518035, China
d Chemical Biology Research at School of Pharmaceutical sciences, Wenzhou Medical University, Wenzhou 325035, China
‡ These authors contributed equally to this work.